Revaccination of Neonatal Calves withMycobacterium bovisBCG Reduces the Level of Protection against Bovine Tuberculosis Induced by a Single Vaccination
Open Access
- 1 November 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (11) , 6411-6419
- https://doi.org/10.1128/iai.71.11.6411-6419.2003
Abstract
Cattle may provide a suitable model for testing ways of improving tuberculosis vaccine efficacy in human infants. A vaccination and challenge study was undertaken in calves to determine the optimal time to vaccinate neonatal animals withMycobacterium bovisbacillus Calmette-Guérin (BCG) for protection against tuberculosis and to determine whether revaccination with BCG was beneficial. Calves (10 per group) were vaccinated with BCG within 8 h of birth or at 6 weeks of age, when immune responses to antigens of environmental mycobacteria were detectable, or vaccinated at birth and revaccinated at 6 weeks. A control group was not vaccinated. BCG vaccination at birth induced strong antigen-specific gamma interferon (IFN-γ) and interleukin-2 (IL-2) responses and antigen-specific activation in CD4+, CD8+, and WC1+γδ T-cell subsets from blood. The proportions of animals per group with macroscopic tuberculous lesions after challenge were 0/10 for BCG at birth, 1/9 for BCG at 6 weeks, 4/10 for the revaccinated group, and 10/10 for the nonvaccinated group. There was no significant difference in the levels of protection between groups vaccinated at birth or at 6 weeks, while animals vaccinated both at birth and at 6 weeks had significantly less protection than those vaccinated only at birth. The revaccinated calves that subsequently developed tuberculous lesions had significantly stronger IFN-γ and IL-2 responses to bovine purified protein derivative after the BCG booster than those in the same group that did not develop lesions. The results indicated that BCG vaccination at birth induced a high level of immunity and that the sensitization of very young animals to antigens of environmental mycobacteria by 6 weeks of age did not affect the effectiveness of BCG. However, BCG revaccination of these young animals was contraindicated.Keywords
This publication has 43 references indexed in Scilit:
- Use of the bovine model of tuberculosis for the development of improved vaccines and diagnosticsTuberculosis, 2003
- Distinct lineages of TH1 cells have differential capacities for memory cell generation in vivoNature Immunology, 2002
- Recombinant BCG vaccinesVaccine, 2001
- Vaccine immunityImmunology Today, 1997
- Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boostingEuropean Journal of Immunology, 1996
- Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccaeResearch in Veterinary Science, 1995
- Identification of a bovine surface antigen uniquely expressed on CD4−CD8− T cell receptor γ/δ+ T lymphocytesEuropean Journal of Immunology, 1990
- A sandwich enzyme immunoassay for bovine interferon‐γ and its use for the detection of tuberculosis in cattleAustralian Veterinary Journal, 1990
- Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system.The Journal of Experimental Medicine, 1989
- How environmental mycobacteria may predetermine the protective efficacy of BCGTubercle, 1981